Home hospital (HH), a care delivery model of providing hospital-grade care to patients in their homes, has become increasingly common in medical settings, though surgical uptake has been limited. HH programs have been shown to be safe and effective in a variety of medical contexts, with increased usage of this care pathway during the COVID-19 pandemic. Though surgical patients have unique clinical considerations, surgical Home Hospital (SHH) programs may have important benefits for this population. Various technologies exist for the delivery of hospital care in the home, such as clinical risk prediction models and remote patient monitoring platforms. Here, we use institutional experiences at Brigham and Women’s Hospital (BWH) to discuss the utility of technology in enabling SHH programs and highlight current limitations. Additionally, we comment on the importance of data interoperability, access for all patients, and clinical workflow design in successfully implementing SHH programs.
家庭醫院 (HH) 是一種為患者在家中提供醫院級護理的護理提供模式，在醫療環境中已變得越來越普遍，儘管手術的採用受到限制。HH 計劃已被證明在各種醫療環境中是安全有效的，在 COVID-19 大流行期間這種護理途徑的使用有所增加。儘管外科手術患者俱有獨特的臨床考慮因素，但外科家庭醫院 (SHH) 計劃可能對該人群有重要益處。存在用於在家提供醫院護理的各種技術，例如臨床風險預測模型和遠程患者監控平台。在這裡，我們利用布萊根婦女醫院 (BWH) 的機構經驗來討論技術在啟用 SHH 計劃中的效用，並強調當前的局限性
【MORE】